Form D · Biotechnology
PellePharm, Inc.
San Francisco, CA · CIK 0001611568
Offering snapshot reported Jul 3, 2018 · SEC filing
- Reported sold
- $7.5M Offering amount: $7.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 18, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 3, 2018 | Initial | $7,500,000 | No comparison | 7 | SEC filing |
| Aug 17, 2016 | Initial | $3,249,998 | No comparison | 4 | SEC filing |
| Oct 14, 2015 | Initial | $719,680 | No comparison | 1 | SEC filing |
| Jul 24, 2015 | Initial | $4,550,000 | No comparison | 1 | SEC filing |
| May 11, 2015 | Initial | $118,625 | No comparison | 1 | SEC filing |
| Apr 21, 2015 | Initial | $1,750,000 | No comparison | 8 | SEC filing |
| Oct 24, 2014 | Initial | $1,250,000 | No comparison | 6 | SEC filing |
| Jul 21, 2014 | Initial | $476,200 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315962
Source: Form D, filed Jul 3, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Katrin Andreasson | Director |
| Mark De Souza | Director, Executive |
| Mark De Souza, Ph.D. | Director, Executive |
| Ervin Epstein | Director, Executive |
| Ervin Epstein, M.D. | Director |
| Neil Kumar | Director |
| Neil Kumar, Ph.D. | Director |
| Frank Mc Cormick | Director |
| Frank Mc Cormick, Ph.D. | Director |
| Sanuj Ravinddran, M.D. | Director, Executive, Promoter |
| Jean Tang | Director |
| Jean Y. Tang, M.D., Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
101 Mission Street, Suite 2050
San Francisco, CA, 94105
San Francisco, CA, 94105